Evidence map›Paper›PMID 40833651›Full record

ArticleDiscover nano2025

Investigating size and surface modification to optimise the delivery of nanodiamonds to brain glial cells.

Manami Takahashi, Ayaka Takada, Chihiro Suzuki, Kiichi Kaminaga, Masaki Yoshioka, Mariko Handa, Jeff Kershaw, Hiroshi Abe, Takeshi Ohshima, Ryuji Igarashi and 1 more

Abstract read
In one paragraph

Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Manami Takahashi *Quantum Neuromapping and Neuromodulation Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Ayaka Takada *Quantum Neuromapping and Neuromodulation Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Chihiro SuzukiDepartment of Quantum Life Science, Graduate School of Science and Engineering, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba, 263-0022, Japan.
Kiichi KaminagaFuture Quantum Sensors Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Masaki YoshiokaQuantum Neuromapping and Neuromodulation Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Mariko HandaQuantum Neuromapping and Neuromodulation Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Jeff KershawDepartment of Molecular Imaging and Theranostics, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
Hiroshi AbeQuantum Materials and Applications Research Center, Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology, 1233 Watanuki-machi, Takasaki City, 370-1292, Gunma, Japan.
Takeshi OhshimaQuantum Materials and Applications Research Center, Takasaki Institute for Advanced Quantum Science, National Institutes for Quantum Science and Technology, 1233 Watanuki-machi, Takasaki City, 370-1292, Gunma, Japan.
Ryuji IgarashiFuture Quantum Sensors Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. igarashi.ryuji@qst.go.jp.
Hiroyuki TakuwaQuantum Neuromapping and Neuromodulation Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. takuwa.hiroyuki@qst.go.jp.

Funding

Japan Society for the Promotion of Science JP23K2139Japan Society for the Promotion of Science JP24K18089Quantum Life Science Flagship Program JPMXS0120330644
6 · The paper itself

Abstract

Nanodiamonds (NDs) with nitrogen-vacancy (NV) defects have garnered attention as promising nano-quantum sensors due to their high photostability, low biotoxicity, and ability to measure intracellular parameters such as temperature, magnetic fields, and electric fields. While NDs have been extensively studied in in vitro systems, their application in vivo remains underdeveloped. Efficient delivery of NDs to specific cells within biological tissues remains a critical challenge for advancing their applications in the life sciences. In this study, we investigated the intracellular uptake of NDs by glial cells (microglia and astrocytes) in the brain. Twelve types of NDs, differing in size (50 nm, 150 nm, 250 nm, and 350 nm) and surface modification (COOH, HPG and HPG-COOH), were locally injected into the brain parenchyma of mice. The intracellular uptake of NDs was assessed using immunostaining and confocal microscopy. Microglia preferentially internalized HPG-modified NDs. HPG-modified NDs also exhibited high diffusivity, facilitating interactions with surrounding microglia and enhancing uptake efficiency. In contrast, COOH-modified NDs were more efficiently internalized by astrocytes than HPG-modified NDs. This suggests that COOH-modified NDs tend to remain at the local injection site, where inflammation induced by tissue damage may have enhanced the phagocytic activity of astrocytes. These findings demonstrate that the uptake characteristics of NDs differ by cell type. HPG-modified NDs, are optimal for microglia, while COOH-modified NDs, are more suitable for astrocytes. It is anticipated that the results of this study will act as an important guide for the use of NDs as nano-quantum sensors in living brain tissues.

Identifiers

PMID40833651
PMCPMC12367616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.